Evidence map›Paper›PMID 18301268›Full record

ReviewCurrent opinion in gastroenterology2008

Vitamin D status in gastrointestinal and liver disease.

Helen M Pappa, Elana Bern, Daniel Kamin, Richard J Grand

Registry-linked trialAbstract readReview
In one paragraph

Review in Current opinion in gastroenterology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01046773 (Vitamin D Supplementation as Non-toxic Immunomodulation in Children With Crohn's Disease), which is not on this map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01046773 phase1terminatednot on this mapstarted 2010, after this paper: background citation

Vitamin D Supplementation as Non-toxic Immunomodulation in Children With Crohn's Disease

TypeinterventionalSponsorUniversity of California, Los AngelesRan2010 to 2017Enrolled3ConditionsCrohn's Disease, Vitamin D DeficiencyArmsCholecalciferol
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Vitamin D for the treatment of inflammatory bowel disease.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Review
  16. Consensus statement from 2Reviews in endocrine & metabolic disorders · 2020
    Article
  17. Review
  18. Article
  19. Article
  20. Bone health and vitamin D status in alcoholic liver disease.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Helen M PappaDivision of Gastroenterology and Nutrition, Department of Medicine, and General Clinical Research Center, Children's Hospital Boston, Boston, Massachusetts, USA.
Elana Bern
Daniel Kamin
Richard J Grand
Boston Children's Hospital · USHarvard University · US

Funding

WIRELESS CAPSULE ENDOSCOPY TO EVALUATE THE SMALL INTESTINE M01RR002172 · NCRR · CHILDREN'S HOSPITAL BOSTON · PI MANDELL, JAMES WILLIAM · 1985 to 2008
$16.0M
NCRR NIH HHS M01 RR002172PHS HHS M01 002172
6 · The paper itself

Abstract

purpose of reviewThe purpose of this review is to report on the vitamin D status and its relationship with bone health in individuals with gastrointestinal and liver disorders. In addition, recommendations regarding replacement and maintenance of optimal vitamin D stores, as well as the state of knowledge regarding its effect on the disease through its actions on the immune system, will be reviewed. RECENT

findingsThe scientific community has revised upward the serum levels of vitamin D considered optimal, and doses of vitamin D much larger than those currently recommended may be needed to maintain these levels, especially in individuals with gastrointestinal and liver disorders. The relationship between vitamin D and bone health in this population is controversial. The role of vitamin D in the regulation of the immune system continues to be elucidated. SUMMARY: Hypovitaminosis D is prevalent among individuals with gastrointestinal and liver disease. Although replacement and supplementation guidelines have not been well defined, practitioners should aim for a serum 25-hydroxyvitamin D level of at least 32 ng/ml. The contribution of vitamin D to the bone health of these individuals and its role in altering disease course through its actions on the immune system remain to be elucidated.

Indexed as

Vitamin D DeficiencyBone DiseasesDigestive System DiseasesGastrointestinal DiseasesHumansImmune SystemImmune System DiseasesLiver DiseasesVitamin D25-hydroxyvitamin DVitamin D

Identifiers

PMID18301268
PMCPMC3805278
OpenAlexW1990867659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.